Indy without Lilly, the 500?
An Indiana University prof thinks Indianapolis should anticipate a future without Indianapolis Motor Speedway, and a potentially
reduced Eli Lilly and Co.
Health Care & Life Sciences
Articles
Q&A: Dr. Kristine Courtney
Dr. Kristine Courtney, Eli Lilly and Co.’s senior director of corporate health services, describes
how and why the company spent two years making its clinics some of the first to electronically swap patient records with
a local hospital database.
Health firms still attracting venture capital
The uncertainty of health care reform and a bad economy curtailed venture capital flow in 2009. That trend hit Indianapolis,
but the rest of the state actually saw an increase.
Dow AgroSciences profit falls despite revenue increase
Indianapolis-based Dow AgroSciences said Tuesday it posted a profit of $69 million in the fourth quarter, down 19 percent
from the prior year because of increased research and development spending and higher administrative expenses. Revenue was
up 17 percent.
Enzon Pharmaceuticals sells Indy drug plant; 100 local jobs safe
New Jersey-based Enzon Pharmaceuticals Inc. has sold its Indianapolis plant that manufactures specialty drugs in a deal that
could top $300 million. The buyer says that the operations, which employ about 100, will remain in the city.
City of Greenwood might fund launch of insulin maker
Greenwood-based Zimmerman Biotechnologies LLC hopes to become the first company in the United States to make generic insulin,
a long-awaited development in diabetes treatment. The Greenwood Common Council on Feb. 1 will consider an $8.4 million deal
that would finance construction of an insulin factory, as well as help Zimmerman with FDA-approval and equipment expenses.
St. Vincent to buy Care Group, city’s largest cardiology practice
St. Vincent Health is near an agreement to take over The Care Group LLC, the city’s largest independent physician practice
and largest cardiology group in the nation.
Health care reform will go on regardless of federal government
Massachusetts’ election of a Republican senator has put health reform legislation on life support. But for the health
care industry, reform is a reality that isn’t going to die.
Federal rule tied to electronic medical records panned
The government has erected a high fence around a pot of $27 billion available to doctors and hospitals that successfully
computerize their patient records by next year, sparking complaints.
Lilly’s profits fall, miss analyst expectations
The Indianapolis-based drugmaker says a weaker dollar depressed earnings in the fourth quarter compared with a year ago.
IU-Kenya Partnership gets $5M USAID grant
A partnership between Indiana University School of Medicine and a medical school and hospital in Kenya has received an additional
$5 million grant from the U.S. Agency for International Development to expand health care services in the African nation.
Express Scripts to add 182 pharmacy jobs by 2012
Drug distribution firm that acquired former WellPoint subsidiary plans to consolidate specialty pharmacy work at local
airport facility.
Two companies set to make major local expansions
Express Scripts Inc. on the west side of Indianapolis and Zipp Speed Weaponry in Speedway are scheduled Wednesday afternoon
to announce the
creation of hundreds of new jobs.
WellPoint beats expectations, lowers ’10 profit forecast
The Indianapolis-based health insurer earned $6.09 per share in 2009, excluding extraordinary items; it expects a $6-per-share
profit in 2010.
Lilly looks to autoimmune drugs
Two local researchers show why Eli Lilly and Co. and its peers are interested in developing medicines to treat automimmune
diseases: The costs of treating them are growing twice as fast as the prescription drug market.
Health care reform dead; long live reform
Massachusetts’ election of a Republican senator has put health reform legislation on life support. But for the health
care industry, reform is a reality that isn’t going to die.
Lilly shares get boost from OK of rival’s drug
Shares of Lilly and partner Amylin rose on hopes that their new version of Byetta will be approved following U.S. regulators’
clearance of a similar drug.
Senate bill would snuff out Indiana’s smoking-cessation agency
Anti-tobacco advocates worry cost-cutting move could seriously diminish state’s efforts to curb Hoosier tobacco use.
Indianapolis hospitals extending reach statewide
St. Vincent Health’s agreement to lease the county hospital in Salem for five years is the latest in a string of deals
by Indianapolis hospital systems seeking a statewide presence.
Indiana GOP wants to block federal health reform mandates
Republicans in the Legislature have joined their counterparts in 25 other states in trying to prevent key aspects of reform
from taking effect in Indiana.